BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Koike H, Okumura T, Murohara T, Katsuno M. Multidisciplinary Approaches for Transthyretin Amyloidosis. Cardiol Ther 2021. [PMID: 34089151 DOI: 10.1007/s40119-021-00222-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Willis C, Watanabe AH, Hughes J, Nolen K, O'Meara J, Schepart A, Bruno M, Biskupiak J, Kawamoto K, Shara N, Kannampallil T. Applying diagnosis support systems in electronic health records to identify wild-type transthyretin amyloid cardiomyopathy risk. Future Cardiol 2022. [PMID: 35098741 DOI: 10.2217/fca-2021-0122] [Reference Citation Analysis]
2 Taniguchi T, Ando M, Okamoto Y, Yoshimura A, Higuchi Y, Hashiguchi A, Matsuda N, Yamamoto M, Dohi E, Takahashi M, Yoshino M, Nomura T, Matsushima M, Yabe I, Sanpei Y, Ishiura H, Mitsui J, Nakagawa M, Tsuji S, Takashima H. Elderly patients with suspected Charcot-Marie-Tooth disease should be tested for the TTR gene for effective treatments. J Hum Genet 2022. [PMID: 35027655 DOI: 10.1038/s10038-021-01005-w] [Reference Citation Analysis]
3 Koike H, Iguchi Y, Sahashi K, Katsuno M. Significance of Oligomeric and Fibrillar Species in Amyloidosis: Insights into Pathophysiology and Treatment. Molecules 2021;26:5091. [PMID: 34443678 DOI: 10.3390/molecules26165091] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
4 Asher C, Guilder A, Finocchiaro G, Carr-White G, Rodríguez-Guadarrama Y. Healthcare resource use associated with the diagnosis of transthyretin amyloidosis cardiomyopathy. Health Sci Rep 2022;5:e466. [PMID: 35024457 DOI: 10.1002/hsr2.466] [Reference Citation Analysis]
5 Di Stefano V, Fava A, Gentile L, Guaraldi P, Leonardi L, Poli L, Tagliapietra M, Vastola M, Fanara S, Ferrero B, Giorgi M, Perfetto F, Russo M, Russo D. Italian Real-Life Experience of Patients with Hereditary Transthyretin Amyloidosis Treated with Patisiran. PGPM 2022;Volume 15:499-514. [DOI: 10.2147/pgpm.s359851] [Reference Citation Analysis]
6 Ismailov RM, Lerut J, Aceña Á, Khasanova ZD. Enhancing knowledge and awareness of transthyretin cardiac amyloidosis and shared decision-making among cardiology team members in Colorado, USA via an online educational initiative. Hosp Pract (1995) 2021;:1-5. [PMID: 34879213 DOI: 10.1080/21548331.2021.2016334] [Reference Citation Analysis]
7 Koike H, Katsuno M. The Ultrastructure of Tissue Damage by Amyloid Fibrils. Molecules 2021;26:4611. [PMID: 34361762 DOI: 10.3390/molecules26154611] [Cited by in F6Publishing: 1] [Reference Citation Analysis]